• OPEN AN ACCOUNT
Indian Indices
Sensex
77,728.16 -281.09
( -0.36%)
Global Indices
Nasdaq
53,757.60 -103.39
(-0.19%)
Dow Jones
7,807.18 -12.81
(-0.16%)
Hang Seng
69,148.70 434.90
(0.63%)
Nikkei 225
10,727.81 -22.30
(-0.21%)
Forex
USD-INR
95.39 0.02
(0.02%)
EUR-INR
109.98 -0.03
(-0.03%)
GBP-INR
128.68 -0.13
(-0.10%)
JPY-INR
0.60 0.00
(-0.03%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.3581313
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
35.72
117138.71
EPS(TTM)
Face Value()
Div & Yield %
40.59
2
0.9
 

Usha Martin consolidated net profit rises 46.35% in the March 2026 quarter
Apr 30,2026
Net profit of Usha Martin rose 46.35% to Rs 147.80 crore in the quarter ended March 2026 as against Rs 100.99 crore during the previous quarter ended March 2025. Sales rose 9.28% to Rs 979.26 crore in the quarter ended March 2026 as against Rs 896.08 crore during the previous quarter ended March 2025.

For the full year,net profit rose 14.38% to Rs 465.99 crore in the year ended March 2026 as against Rs 407.39 crore during the previous year ended March 2025. Sales rose 6.24% to Rs 3691.06 crore in the year ended March 2026 as against Rs 3474.16 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales979.26896.08 9 3691.063474.16 6
OPM %21.6015.58 -19.1017.19 -
PBDT239.13160.88 49 772.84624.71 24
PBT207.89133.12 56 656.44526.85 25
NP147.80100.99 46 465.99407.39 14